Integrated DIA proteomics and lipidomics analysis on non-small cell lung cancer patients with TCM syndromes

被引：0
|
作者：
Song Cang
Ran Liu
Wei Jin
Qi Tang
Wanjun Li
Kunqian Mu
Pengfei Jin
Kaishun Bi
Qing Li
机构：
[1] Shenyang Pharmaceutical University,School of Pharmacy, National and Local Joint Engineering Laboratory for Key Technology of Chinese Material Medica Quality Control
[2] Shenzhen Polytechnic,School of Applied Chemistry and Biological Technology
[3] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Chinese Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[4] Chinese Academy of Medical Science,Department of Pharmaceutical Science, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine
来源：
Chinese Medicine | / 16卷
关键词：
Non-small cell lung cancer; Traditional Chinese medicine syndromes; Syndrome differentiation; Lipidomics; Proteomics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Integrated DIA proteomics and lipidomics analysis on non-small cell lung cancer patients with TCM syndromes
    Cang, Song
    Liu, Ran
    Jin, Wei
    Tang, Qi
    Li, Wanjun
    Mu, Kunqian
    Jin, Pengfei
    Bi, Kaishun
    Li, Qing
    CHINESE MEDICINE, 2021, 16 (01)
  • [2] Metabolomics and lipidomics in non-small cell lung cancer
    Shi, Wei
    Cheng, Yizhen
    Zhu, Haihua
    Zhao, Longshan
    CLINICA CHIMICA ACTA, 2024, 555
  • [3] Proteomics biomarkers for non-small cell lung cancer
    Kisluk, Joanna
    Ciborowski, Michal
    Niemira, Magdalena
    Kretowski, Adam
    Niklinski, Jacek
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 101 : 40 - 49
  • [4] Comparative Proteomics and Bioinformatics Analysis of Tissue from Non-Small Cell Lung Cancer Patients
    Gezici, Sevgi
    Ozaslan, Mehmet
    Akpinar, Gurler
    Kasap, Murat
    Sanli, Maruf
    Elbeyli, Levent
    CURRENT PROTEOMICS, 2017, 14 (01) : 58 - 77
  • [5] Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer
    Chen, Yingrong
    Ma, Zhihong
    Shen, Xiongrong
    Li, Liqin
    Zhong, Jing
    Min, Li Shan
    Xu, Limin
    Li, Hongwei
    Zhang, Jianbin
    Dai, Licheng
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [6] ASSESSING THE UTILIZATION OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A511 - A511
  • [7] Complicated paraneoplastic neurological syndromes: a report of two patients with small cell or non-small cell lung cancer
    Hiasa, Y
    Kunishige, M
    Mitsui, T
    Kondo, S
    Kuriwaka, R
    Shigekiyo, S
    Kanematsu, T
    Satake, N
    Bando, Y
    Kondo, A
    Endo, I
    Oshima, Y
    Matsumoto, T
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2003, 106 (01) : 47 - 49
  • [8] Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer
    Titmarsh, Helen F.
    von Kriegsheim, Alex
    Wills, Jimi C.
    O'Connor, Richard A.
    Dhaliwal, Kevin
    Frame, Margaret C.
    Pattle, Samuel B.
    Dorward, David A.
    Byron, Adam
    Akram, Ahsan R.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Circulating tumor cell analysis in patients with non-small cell lung cancer
    Kato, T.
    Yamada, K.
    Nokihara, H.
    Fukui, T.
    Yamamoto, N.
    Sekine, I.
    Kunitoh, H.
    Ohe, Y.
    Koizumi, F.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Predictive biomarker analysis of non-small cell lung cancer patients
    Sakellariou, S.
    Karatrasoglou, E. A.
    Chatziandreou, I.
    Giannopoulou, I.
    Michelli, M.
    Zougros, A.
    Rouppou, E.
    Stamopoulos, K.
    Lazaris, A. C.
    Korkolopoulou, P.
    Saetta, A.
    VIRCHOWS ARCHIV, 2019, 475 : S105 - S105
12345